The coronavirus disease 2019 (COVID-19) pandemic has dramatically changed the care provided to many patients with genitourinary cancers. This has necessitated a transition to telemedicine, changes in threshold, or delays in many treatments, and an opportunity to reimagine patient care to maintain safety and improve value moving forward.
Surgery remains the standard for lymph-node (LN) metastatic penile cancer. Surveillance or delayed LN dissection (LND) risks missing a curative opportunity. Minimally invasive techniques seem…
Surgery remains the standard for lymph-node (LN) metastatic penile cancer. Surveillance or delayed LN dissection (LND) risks missing a curative opportunity. Minimally invasive techniques seem…
More great highlights from the latest edition of European Urology!! Here on the European Urology Podcast we bring you selected highlights each month with som…
Circulating tumour DNA (ctDNA) has clinical applications as a “liquid biopsy” owing to its short half-life, noninvasive collection modalities, and propensity for sampling across populations…
7,665 Followers, 4 Following, 482 Posts – See Instagram photos and videos from European Urology (@euro_urol)
The European Urology Podcast posts every month with highlights of the latest edition of European Urology. This podcast is co-hosted by Urologists Professor Declan Murphy…
Rare cancers account for 20–25% of all cancers diagnosed annually but there is no consensus on the definition of a rare cancer and substantial geographic…
Metastasis-directed therapy results in promising clinical outcomes and low rates of adverse events. It can be a valuable treatment option either for oligorecurrent patients wishing…
7,665 Followers, 4 Following, 482 Posts – See Instagram photos and videos from European Urology (@euro_urol)
Localized prostate cancer can be treated effectively with minimally invasive whole-gland ablation with comparable intermediate- to long-term oncological control with excellent pad-free continence rate at…
